YaoGeJu

Company directoryChina company filings

Hunan Ouya Pharmaceutical Co.,Ltd

As of 18 November 2026, for the company name Hunan Ouya Pharmaceutical Co.,Ltd as recorded, 20 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

3 acceptance records as first applicant, grouped into 2 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Deferasirox Tablets 2 records · Latest accepted 2026/01/16

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600193Generic2026/01/16Hunan Ouya Pharmaceutical Co.,Ltd; Beijing Cheng Ji Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2600192Generic2026/01/16Hunan Ouya Pharmaceutical Co.,Ltd; Beijing Cheng Ji Pharmaceutical Co., Ltd. romanizedCDE ↗
磷酸奥司他韦颗粒 · No verified English name 1 records · Latest accepted 2025/08/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503065Generic2025/08/21Hunan Ouya Pharmaceutical Co.,Ltd; Hunan Jia Heng Pharmaceutical Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Deferasirox Tablets CYHS2600193Generic2026/01/16Hunan Ouya Pharmaceutical Co.,Ltd; Beijing Cheng Ji Pharmaceutical Co., Ltd. romanizedCDE ↗
Deferasirox Tablets CYHS2600192Generic2026/01/16Hunan Ouya Pharmaceutical Co.,Ltd; Beijing Cheng Ji Pharmaceutical Co., Ltd. romanizedCDE ↗
磷酸奥司他韦颗粒 · No verified English name CYHS2503065Generic2025/08/21Hunan Ouya Pharmaceutical Co.,Ltd; Hunan Jia Heng Pharmaceutical Co., Ltd. romanizedCDE ↗

Catalogue holder records

0 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
No matching records were found in the currently loaded source data; coverage dates are listed below.

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

20 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
玛巴洛沙韦 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20260000178I2026/03/18CDE ↗
妥洛特罗 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20260000135I2026/03/05CDE ↗
地拉罗司 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20250001398I2025/12/18CDE ↗
艾瑞昔布 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20250001323I2025/12/05CDE ↗
艾氟洛芬 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20250000271I2025/03/28CDE ↗
磷苯妥英钠 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20250000049A2026/08/13CDE ↗
氟比洛芬 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20250000221A2026/08/13CDE ↗
罗替高汀 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20240001515A2026/07/14CDE ↗
甲磺酸达比加群酯 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20240000459A2025/12/10CDE ↗
利可君 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20230001256I2024/10/17CDE ↗
双氯芬酸依泊胺 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20230001281I2023/12/26CDE ↗
双氯芬酸二乙胺 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20230001257A2026/09/02CDE ↗
右兰索拉唑 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20230000161A2024/09/02CDE ↗
吲哚布芬 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20220001284A2026/09/02CDE ↗
氯苯唑酸葡胺 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20220000947A2026/04/08CDE ↗
磷酸奥司他韦 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20220000508A2025/09/11CDE ↗
呋塞米 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20220000566A2026/04/08CDE ↗
奥美沙坦酯 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20200000249A2026/03/21CDE ↗
格拉司琼 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20260000950I2026/11/11CDE ↗
碳[13C]-尿素 · No verified English nameHunan Ouya Pharmaceutical Co.,LtdY20260000965I2026/11/17CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.